Enrolment concludes in Lynch’s Phase II rhPDGF-BB study

​

Lynch Regenerative Medicine has completed participant enrolment in a Phase II trial assessing the rhPDGF-BB as an adjunctive therapy for surgical wounds following skin cancer excision.

The post Enrolment concludes in Lynch’s Phase II rhPDGF-BB study appeared first on Hospital Management.

 

Back to the Featured Stories
Enrolment concludes in Lynch’s Phase II rhPDGF-BB study

Featured Stories

Hyperfine concludes Contrast PMR study enrolment for Swoop MRI system
Arrowhead reports top-line results in mixed hyperlipidaemia trial
Eli Lilly and QurCan sign genetic medicine deal
BRAINBox and Prolight sign supply agreement for concussion tests
Taiho, Cullinan report improved PFS in Phase III NSCLC trial

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us